Single-use bioreactors in various designs have been introduced onto the market over the last decade. At small scale, there are many potential solutions, including classic shake flasks in single-use ...
Global Single Use Bioreactors Markets, 2023-2035 - Rising Interest in Large Scale Disposable Bioreactors for Single use Bioprocessing - ResearchAndMarkets.com October 23, 2023 11:34 AM Eastern ...
Sartorius AG is a prominent player in the single-use bioreactors market, catering to biopharmaceutical and pharmaceutical companies, CMOs, and CROs. The company stands out for its comprehensive range ...
Single-Use Systems Slowly but Surely Gaining Acceptance in Critial Unit Operations Disposable bioreactors have become the vanguard of single-use processing, a litmus test of sorts for the acceptance ...
The G3Lite+ controller continues to leverage Finesse's SmartParts™ to deliver industrial automation reliability and scalability in a very affordable package. The controller can accommodate up to four ...
According to the new market research report Single use Bioreactors Market is projected to reach $3.9 billion by 2025, at a CAGR of 18.0% during the forecast period. Based on product, the market is ...
The addition of the 50-liter single-use bioreactor significantly expands Cellipont's cGMP-compliant capacity, enabling clients to seamlessly transition from early development to large-scale, ...
DUBLIN--(BUSINESS WIRE)--The "Single-use Bioreactor Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The Global Single-use Bioreactor ...
CHICAGO, Sept. 29, 2020 /PRNewswire/ -- According to the new market research report "Single use Bioreactors Market by Product (System, Media Bag, Filtration Assemblies), Type (Stirred tank, Bubble ...
PUNE, India, Feb. 24, 2021 /PRNewswire/ -- Global demand for Single-Use Bioreactor Market Size, in terms of revenue, was worth of USD 1.10 Billion in 2017 and is expected to reach USD 4.50 Billion in ...
Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
WUXI, China, Feb. 8, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that its MFG5 Drug Substance ...